Title
BFAD Standards on Whitening Agents
Law
Bfad Bureau Circular No. 4-b S. 200
Decision Date
Apr 3, 2004
The Bureau of Food and Drugs establishes safety standards for cosmetic whitening agents, detailing accepted ingredients and their permissible concentration levels to ensure consumer safety and product efficacy.
A

Criteria for Whitening Agents and Concentrations

  • Whitening agents must be effective at the minimum concentration and safe up to the maximum concentration identified.
  • Concentration levels are based on clinical trials and product information from various sources.
  • The list includes both natural extracts and chemical compounds.

List of Accepted Whitening Agents and Recommended Concentrations

  • GIGAWHITE: 0.2% to 5%
  • DERMWHITE: 0.5% to 2%
  • PAPAYA EXTRACT: 1% to 5%
  • PAPAIN EXTRACT: 0.2% to 0.5%
  • MULBERRY EXTRACT (powder): 0.10% to 1%, (liquid): 1% to 5%
  • LACTIC ACID (Exfoliant): 1% to 10%
  • MELAWHITE: 2% to 4%
  • VITAMIN C variants:
    • Rovisome C: 1% to 5%
    • Glycosphere Vitamin C: 0.2% to 5%
    • Vitaceton: 1% to 5%
  • MAGNESIUM ASCORBYL PHOSPHATE (MAP): 0.01% to 18.5%
  • SODIUM LACTATE: 10% to 12%
  • BEARBERRY EXTRACT (MELFADE): 3% to 10%
  • LICORICE EXTRACT: 0.0003% to 1%
  • KOJIC ACID: 2.0%
  • UNINONTAN U-34 (Sodium Citrate Lemon Extract and Cucumber Extract): 5.0%

Safety and Regulatory Compliance

  • Products must be formulated within the specified concentration range to guarantee safety and efficacy.
  • The BFAD retains authority to revise, update, or delist any whitening agents based on new safety evidence or introduction of more effective substances.
  • Manufacturers and distributors are required to comply with the standards established by the circular.

Authority and Enforcement

  • Enacted and signed by the BFAD Director, Prof. Leticia Barbara B. Gutierrez, MS, on April 3, 2004.
  • The circular serves as a regulative instrument for BFAD in evaluating cosmetic products containing whitening agents.

Important Legal Concepts

  • Ensuring consumer safety through regulated concentration limits.
  • Continuous monitoring and possible revision of accepted whitening agents.
  • Balance between product effectiveness and minimal adverse reactions.
  • BFAD’s mandate to safeguard public health in cosmetic use.

Analyze Cases Smarter, Faster
Jur helps you analyze cases smarter to comprehend faster, building context before diving into full texts. AI-powered analysis, always verify critical details.